I just looked at you know who's twitter and there is a tweet from December 3rd called STAT in NYC and the event is tonight. The main topics are related to lecanemab and Eisai's Alzheimer's Plan. Based on the conference call this morning we blow that drug out of the water on both efficacy and safety (not to mention ease of use). I guess I now understand who works for who and why the outright lies are being told about A-273. Wow....what a crazy world!